Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Pfizer, Clinician",Apixaban,Anticoagulation therapy - open listing,Apixaban,Options for investment,,Blood and Blood Forming Organs
